Nalgonda: DCA seizes Minoxytop 10% over misleading claims about hair growth
The drug was circulated in the market with a claim that it helps in the "growth of new hair"
By Newsmeter Network Published on 6 March 2024 6:02 AM GMT
Telangana: Drugs Control Administration in Nalgonda seized the stock of Minoxytop 10% (Minoxidil Topical solution USP 10% w/v) after receiving reports about misleading hair growth claims.
The drug was circulated in the market with a claim that it helps in the "growth of new hair". After analysis, the claim was found to be misleading.
On March 5, officials from the Drugs Control Administration in Nalgonda Zone conducted raids at Sairam Pharma and Surgicals in Nalgonda and seized the stock.
'Minoxytop 10%', is manufactured by Healing Pharma India Pvt. Ltd located in Gujarat.
The claim regarding the āgrowth of new hairā is prohibited under 'Schedule J' of the Drugs Rules. The misleading claim states that the drug is useful in āhair regrowth and that it reactivates hair follicles to stimulate regrowthā.
"Schedule J of the Drugs Rules prohibits claims of drugs for the treatment of certain diseases and disorders. No drug shall claim on its label that it prevents or cures diseases/disorders indicated under Schedule J of the Drugs Rules," said K. Dass, Assistant Director of DCA Nalgonda who was part of the raids.
How to report?
Firms that manufacture drugs with misleading claims regarding the treatment of certain diseases and disorders are punishable under the Drugs and Cosmetics Act. Offenders may face imprisonment for a term extending up to two years, along with a fine.
The public may report any complaints regarding illegal activities concerning medicines through the Drugs Control Administration (DCA), Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.
